Evidence map›Paper›PMID 39799543›Full record

ArticleJournal of nephrology2025

Depression and anxiety in people with kidney disease: understanding symptom variability, patient experience and preferences for mental health support.

Joseph Chilcot, Christina J Pearce, Natalie Hall, Zara Rehman, Sam Norton, Sophie Griffiths, Joanna L Hudson, Lucy Mackintosh, Amanda Busby, David Wellsted and 12 more

Abstract read
In one paragraph

Article in Journal of nephrology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Joseph ChilcotDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK. joseph.chilcot@kcl.ac.uk.ORCID http://orcid.org/0000-0001-6427-4690
Christina J PearceDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Natalie HallSchool of Life and Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield, UK.
Zara RehmanDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Sam NortonDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Sophie GriffithsDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Joanna L HudsonDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Lucy MackintoshSchool of Life and Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield, UK.
Amanda BusbySchool of Life and Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield, UK.
David WellstedSchool of Life and Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield, UK.
Julia JonesSchool of Health and Social Work, University of Hertfordshire, Hatfield, UK.
Shivani SharmaAston Business School, Aston University, Birmingham, UK.
Paula OrmandySchool of Health and Society, University of Salford, Salford, UK.
Nick PalmerKidney Care UK, Alton, UK.
Pooja SchmillDepartment of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, 5th Floor Bermondsey Wing, Guy's Campus, London Bridge, London, SE1 9RT, UK.
Maria Da Silva-GaneRenal Unit, Lister Hospital, Stevenage, UK.
Neal MorganDaisy Hill Hospital, Southern Health and Social Care Trust, Craigavon, Northern Ireland, UK.
Dimitrios PoulikakosSalford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Salford, UK.
Kristin VeigheyUniversity Hospital Southampton, NHS Foundation Trust, Southampton, UK.
Stuart RobertsonWrexham Maelor Hospital, Wales, UK.
Rob EliasKing's College Hospital, NHS Foundation Trust, London, UK.
Ken FarringtonSchool of Life and Medical Sciences, University of Hertfordshire, College Lane Campus, Hatfield, UK.

Funding

Kidney Research UK and The Stoneygate Trust KS_RP_006_20190919
6 · The paper itself

Abstract

backgroundDepression and anxiety are commonly experienced by people with chronic kidney disease (CKD). This study aimed to evaluate person- and service-level factors associated with depression and anxiety symptoms. We sought to also understand utilisation of mental health treatments and preferences for future psychological support.

methodsAn online survey recruited participants from six UK kidney services with varying levels of psychosocial provision. The survey was also advertised on social media. Participants completed screening questionnaires for depression and anxiety, alongside questions about mental health history, self-efficacy, treatment and support. The study included adults (18 years or older) living with CKD (stages 3b and above) or those receiving any form of Kidney Replacement Therapy (KRT), including individuals with a functioning kidney transplant. Eligible participants had to complete study measures and be proficient in reading and writing in either English or Welsh, as the survey was administered in these languages. This survey was developed with our Patient and Public Involvement group and was administered from January 2023 until 31st January, 2024 using Qualtrics and RedCap.

resultsFour hundred fifty-eight people completed the survey. Moderate-severe symptoms of depression and anxiety were 37.7% and 26.5%, respectively. Over 50% reported a history of diagnosed depression. In addition to depression, sleep problems and fatigue were identified as future support needs, with over a third indicating a preference for in-centre provision. In case-mix adjusted analysis, there was no variability in depression and anxiety symptoms across centres. Centre location and size were unrelated to symptoms. Age, female gender, current mental health treatments, self-efficacy and perceptions regarding opportunity for support, were associated with symptoms of depression and anxiety. In sub-analysis, there was a negative association between psychosocial staffing levels and depression symptoms.

conclusionPatient-related factors and behavioural characteristics were related to variation of these symptoms. There was little evidence of symptom variability across centres, although in a small sub-analysis, psychosocial provision showed a weak negative correlation with depression symptoms. Our findings highlight preferences of future needs which could be helpful for designing future research and service provision.

Indexed as

AnxietyDepressionPatient PreferenceRenal Insufficiency, ChronicAdultAgedFemaleHumansMaleMental HealthMiddle AgedSurveys and QuestionnairesUnited KingdomAnxietyChronic kidney diseaseDepressionMental health

Identifiers

PMID39799543
PMCPMC11961520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.